Home » Topics » Disease categories and therapies » Infection

Infection
RSS

News from ICMASKO 5: Pliva describes new azalides

Feb. 4, 2000

InterMune begins phase II trial of Actimmune in cryptococcal meningitis

Feb. 4, 2000

Telithromycin featured in multiple presentations at ICMASKO 5

Feb. 4, 2000

Sporanox Injection now available for treatment of serious fungal infections

Feb. 4, 2000

Pliva presents new azithromycin derivatives at ICMASKO 5

Feb. 3, 2000

BMS informs of first launch for new quinolone

Feb. 3, 2000

Potent, broad-spectrum cephalosporins in development at Roche

Feb. 3, 2000

Focus on carbapenem modifications continues at Merck

Feb. 3, 2000

Novel isatin derivatives with broad-spectrum antibacterial and antifungal activity

Feb. 3, 2000

Cerus continues phase III trial of platelet pathogen inactivation system in Europe

Feb. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...